E2O SOLUTIONS
We bring you solutions through evidence and methods innovation

Best Evidence-based Recommendations
We conduct State of Art Clinical Practice Guidelines

Solutions for Not-For-Profit Organizations
Expert Guidance
We produce state of art evidence synthesis products to help organizations make critical decisions, engage members, increase impact, and disseminate and implement the latest available evidence.

Solutions for Industries
The Path to Success
We use advanced technology, big data, the latest methods, and world-class expertise to bring you the best solutions for your business from the beginning to the end of the product lifecycle.
WHAT WE CAN HELP YOU WITH
Clinical Practice Guidelines
We conduct, adapt, and facilitate the development of state of art clinical practice guidelines with our extensive clinical and methodological experiences on treatment, diagnosis and prognosis related topics.
Evidence Mapping & Synthesis
We design and conduct various evidence mapping and synthesis projects to help you understand the current evidence landscape, the current treatment options, and obtain the most comprehensive relative effectiveness of interventions or diagnostic strategies.
Health Economic Evaluations
We perform individual health economic evaluations as well as provide packages that include such evaluations for Health Technology Assessment and Value Dossiers submissions.
Patient-Reported Outcomes
We provide patient-reported outcomes (PRO) related study designs in regard to how to choose and implement instruments, how and when to collect PRO data in different study design such as health economic evaluation and Randomized Controlled Trials. We can also help you better analyzing, reporting and interpreting your PRO data.
Minimal Important Difference
Access the most comprehensive databases on all available anchor based minimal important difference (MID)s for different patient-reported outcomes across all therapeutic areas. Having access to this will help you interpret the patient-reported outcomes.
China Market Access
We facilitate the key steps to enter Chinese markets from national level to provincial level utilizing health economics, real-world evidence, and multiple stakeholders' involvement (payer, government and key opinion leaders, etc).
WHY US?

1,300
Publications

100,000+
Times cited

95%
PhD/MSc/M.D.
